Cited by 811Health Systems, Economic Evaluations, Quality of LifeEconomic and Environmental ValuationPharmaceutical Economics and Policy

The DOI matches its Crossref record; 183 of the 184 references it cites were found in a registry or an index.

Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

Open access

Ramsey, Scott D., Willke, Richard J., Glick, Henry, Reed, Shelby D., Augustovski, Federico, Jonsson, Bengt, Briggs, Andrew, Sullivan, Sean D.·2015·Value in Health

DOI 10.1016/j.jval.2015.02.001

Open this paper in CoChat — free account

Abstract

Clinical trials evaluating medicines, medical devices, and procedures now commonly assess the economic value of these interventions. The growing number of prospective clinical/economic trials reflects both widespread interest in economic information for new technologies and the regulatory and reimbursement requirements of many countries that now consider evidence of economic value along with clinical efficacy. As decision makers increasingly demand evidence of economic value for health care interventions, conducting high-quality economic analyses alongside clinical studies is desirable because they broaden the scope of information available on a particular intervention, and can efficiently provide timely information with high internal and, when designed and analyzed properly, reasonable external validity. In 2005, ISPOR published the Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force report. ISPOR initiated an update of the report in 2014 to include the methodological developments over the last 9 years. This report provides updated recommendations reflecting advances in several areas related to trial design, selecting data elements, database design and management, analysis, and reporting of results. Task force members note that trials should be designed to evaluate effectiveness (rather than efficacy) when possible, should include clinical outcome measures, and should obtain health resource use and health state utilities directly from study subjects. Collection of economic data should be fully integrated into the study. An incremental analysis should be conducted with an intention-to-treat approach, complemented by relevant subgroup analyses. Uncertainty should be characterized. Articles should adhere to established standards for reporting results of cost-effectiveness analyses. Economic studies alongside trials are complementary to other evaluations (e.g., modeling studies) as information for decision makers who consider evidence of economic value along with clinical efficacy when making resource allocation decisions.

Integrity signals

Registry

Crossref · 10.1016/j.jval.2015.02.001

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
World Development indicators
Awais, A. (2015) · Data Archiving and Networked Services (DANS) · doi:10.17632/zcvgc6m58h.1 · Cited by 6,790
Statistical Analysis With Missing Data
Ghosh, S., Little, R. J. A., & Rubin, D. B. (1988) · Technometrics · doi:10.2307/1269814 · Cited by 4,730
Untitled work
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544

Flagged first, then by citations

Show all 184 references

1 of the 184 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Sullivan, 2001, Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial, Control Clin Trials, 22, 420, 10.1016/S0197-2456(01)00137-4 · DOI
Barber, 2000, Analysis of cost data in randomized trials: an application of the nonparametric bootstrap, Stat Med, 19, 3219, 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P · DOI

Sorted by citations

Items 401–500 of 810

Medical management of early pregnancy loss is cost-effective compared with office uterine aspiration
Nagendra, D., Gutman, S. M., Koelper, N., Loza-Avalos, S. E., Sonalkar, S., Schreiber, C. A., & Harvie, H. S. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.06.054 · Cited by 6
Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia®)
Costa, S., Guerreiro, J., Teixeira, I., Helling, D. K., Pereira, J., & Mateus, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.903270 · Cited by 6
“The cost of implementing the intervention/usual care is derived from the limited societal perspective as per recommendations of economic evaluations alongside trials (Ramsey et al., 2005; Ramsey et al., 2015) and as per the ISPOR Drug Task Force Report II (Garrison et al.”
BackgroundMethod
Economic evaluation in cardiac electrophysiology: Determining the value of emerging technologies
Hijazi, W., Vandenberk, B., Rennert‐May, E., Quinn, A. E., Sumner, G., & Chew, D. S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1142429 · Cited by 7
Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients
Tew, M., Douglas, A., Szer, J., Bajel, A., Harrison, S. J., Tio, S. Y., Worth, L. J., Hicks, R., Ritchie, D., Slavin, M., et al. (2023) · Cancer Imaging · doi:10.1186/s40644-023-00647-7 · Cited by 5
“The economic evaluation follows the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) guideline for trial-based cost-effectiveness analysis [14] and reporting follows the ISPOR consolidated health economic evaluation reporting standards guideline (Appendix 1) [15].”
Method
RISEinFAMILY project: the integration of families at neonatal intensive care units (NICUs) to empower them as primary caregivers: study protocol for a stepped wedge cluster controlled trial
Alferink, M. T., Sanz-Gadea, B. M., Cabrera‐Lafuente, M., Ergenekon, E., de Haan, T. R., van Kempen, A. A. M. W., Lakhwani, J., Rabe, H., Zaharie, G. C., & Pellicer, A. (2024) · Trials · doi:10.1186/s13063-024-08043-7 · Cited by 7
“The cost-effectiveness analysis of RISEinFAMILY implementation will be carried out using recommended methods [35, 36].”
Method
Cost-effectiveness of strength exercise or aerobic exercise compared with usual care for patients with knee osteoarthritis: secondary results from a multiarm randomised controlled trial in Norway
Killingmo, R. M., Øiestad, B. E., Risberg, M. A., Maas, E. T., & Grotle, M. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-079704 · Cited by 6
“6 12 18–20 Therefore, the aim of this study was to evaluate the 1-year CE of SE or AE compared with UC for patients with symptomatic knee OA, from a societal and health-care perspective.”
Background
Cost-effectiveness of a short-course antibiotic treatment strategy for the treatment of ventilator-associated pneumonia: an economic analysis of the REGARD-VAP trial
Cai, Y., Booraphun, S., Li, A., Kayastha, G. K., Tambyah, P. A., Cooper, B. S., Graves, N., & Mo, Y. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00327-9 · Cited by 6
Long‐term cost‐effectiveness of invasive urodynamic studies for overactive bladder in women
Bell‐Gorrod, H., Thokala, P., Breeman, S., Cooper, D., MacLennan, G., Abdel‐Fattah, M., & Dixon, S. (2025) · British Journal of Urology · doi:10.1111/bju.16703 · Cited by 6
“The modelling methods are in line with those of the NICE [7], whilst the trial-based analysis follows international methodological guidelines [8].”
Cost-effectiveness of physical activity intervention in children – results based on the Physical Activity and Nutrition in Children (PANIC) study
Kuvaja-Köllner, V., Lintu, N., Lindi, V., Rissanen, E., Eloranta, A., Kiiskinen, S., Martikainen, J. A., Kankaanpää, E., Valtonen, H. J., & Lakka, T. A. (2021) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-021-01181-0 · Cited by 7
Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT
Dasgupta, R., Cameron, S., Aucott, L., MacLennan, G., Kilonzo, M. M., Lam, T. B., Thomas, R., Norrie, J. D., McDonald, A., Anson, K. M., et al. (2022) · Health Technology Assessment · doi:10.3310/wuzw9042 · Cited by 6
The EVO study protocol for a randomized controlled evaluation trial of an optimized weight management intervention
Pfammatter, A. F., Battalio, S. L., Olvera, C., Dezelar, M., Moore, D., Scanlan, L., Siddique, J., Spring, B. J., & Chang, S. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106750 · Cited by 6
A systematic review of economic evaluations for the interventions of superficial basal cell carcinoma
van Delft, L. C. J., Kelleners-Smeets, N. W. J., Peeters, A., Mosterd, K., & Essers, B. A. B. (2023) · EJC Skin Cancer · doi:10.1016/j.ejcskn.2023.100008 · Cited by 6
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial
Pyne, S., Sach, T., Lawrence, M. M., Renz, S., Eminton, Z. B., Stuart, B. L., Thomas, K. S., Francis, N. A., Soulsby, I., Thomas, K., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073245 · Cited by 6
Cost-effectiveness of prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) versus usual care – Protocol for a health economic evaluation alongside a randomized controlled trial
Eckhardt, H., Quentin, W., Silzle, J., Busse, R., & Rombey, T. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04833-5 · Cited by 5
“The methods were guided by ISPOR recommendations on Good Research Practice in cost-effectiveness analysis alongside clinical trials [23] and by relevant textbooks [24].”
Method
Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT
Hollingworth, W., Fawsitt, C. G., Dixon, P., Duffy, L., Araya, R., Peters, T. J., Thom, H. H. Z., Welton, N. J., Wiles, N., Lewis, G., et al. (2019) · PharmacoEconomics - Open · doi:10.1007/s41669-019-00188-5 · Cited by 6
“However, NICE and other method guides [38] do not specify how cost-effectiveness subgroup analyses should be conducted or interpreted.”
Background
Cost-effectiveness of Practice Team-Supported Exposure Training for Panic Disorder and Agoraphobia in Primary Care: a Cluster-Randomized Trial
Brettschneider, C., Gensichen, J. S., Hiller, T. S., Breitbart, J., Schumacher, U., Lukaschek, K., Teismann, T., Margraf, J., & König, H. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-05658-9 · Cited by 6
Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis
Hunter, S. F., Bindra, J., Chopra, I., Niewoehner, J., Panaccio, M. P., & Wan, G. J. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s330118 · Cited by 6
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E. W., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.cheers · Cited by 7
Self-citation
Cost-Effectiveness of Drug-Coated Balloon Angioplasty Versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Chronic Limb-Threatening Ischemia: The SINGA-PACLI Trial
Sivapragasam, N. R., Matchar, D. B., Zhuang, K. D., Patel, A. K., Pua, U., Win, H. H., Chandramohan, S., Venkatanarasimha, N. K., Chua, J. M. E., Tan, G. W. L., et al. (2022) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-022-03073-7 · Cited by 6
“The analysis followed principles set by the Second Panel on Cost-Effectiveness in Health and Medicine [25] and the International Society for Pharmacoeconomics and Outcomes Research Good Practices Task Force [26].”
Cost-effectiveness analysis of using oral magnesium supplementation in the treatment of prediabetes
Guerrero‐Romero, F., & Nevárez-Sida, A. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.03.013 · Cited by 6
Cost-effectiveness of motivational counselling and text reminders in patients with rheumatoid arthritis: results based on a randomised clinical trial
Sørensen, J. R., Esbensen, B. A., Aadahl, M., Hetland, M. L., & Thomsen, T. (2022) · RMD Open · doi:10.1136/rmdopen-2022-002304 · Cited by 6
“The cost-effectiveness analysis (CEA) was conducted from a regional healthcare funder perspective in accordance with international guidelines for economic evaluations alongside clinical trials 18 19 and reported according to international standards 20 and adhering to current Danish guidelines.”
How can we associate an economic evaluation with a clinical trial?
Braga, M. M., Machado, G. M., Rocha, E. S., Viganó, M. E. F., Pontes, L. R. A., & Raggio, D. P. (2020) · Brazilian Oral Research · doi:10.1590/1807-3107bor-2020.vol34.0076 · Cited by 6
Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma
Zarca, K., Mimouni, M., Pereira, H., Châtellier, G., Vilgrain, V., Durand‐Zaleski, I., Assénat, E., Delhom-Christol, E., Guiu, B., Ilonca, A. D., et al. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.04.018 · Cited by 6
Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting
Muresan, B., Mamolo, C. M., Cappelleri, J. C., Postma, M. J., & Heeg, B. M. S. (2021) · Applied Health Economics and Health Policy · doi:10.1007/s40258-021-00666-0 · Cited by 6
“All analyses were conducted according to the ISPOR guidelines on good research practices for cost-effectiveness analysis alongside clinical trials [16, 17].”
Method
An economic evaluation of deep brain stimulation for patients with Parkinson's disease
Dams, J., & Dodel, R. C. (2016) · Movement Disorders · doi:10.1002/mds.26701 · Cited by 6
Economic Evaluation of a Multicomponent mHealth Intervention for Stroke Management in Rural China: Cluster-Randomized Trial With 6-Year Follow-Up
Yang, B., Gong, E., Chen, X., Tan, J., Peoples, N., Li, Y., Cai, J., Li, Y., Oldenburg, B. F., Chen, C., et al. (2025) · JMIR mhealth and uhealth · doi:10.2196/75326 · Cited by 4
“Although the effectiveness of the SINEMA model has been demonstrated through a cluster-randomized implementation trial and long-term follow-up [10,11], guidelines emphasize the importance of recording on-site costs to validate the cost-effectiveness of such intervention trials [12].”
Economic Evaluation of Early Interventions for Autistic Children: A Scoping Review
Pye, K., Jackson, H., Iacono, T. A., & Shiell, A. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-05938-3 · Cited by 5
“In healthcare, researchers are increasingly conducting economic evaluations alongside clinical trials (Ramsey et al., 2015).”
Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trial
Huang, L., Dalziel, K., Lloyd, M., Loke, P., Lozinsky, A. C., & Tang, M.-M. L. K. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075521 · Cited by 4
Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people
Sach, T., Onoja, M., Clarke, H., Santer, M., Müller, I., Becque, T., Stuart, B. L., Hooper, J., Steele, M., Wilczynska, S., et al. (2024) · The European Journal of Health Economics · doi:10.1007/s10198-023-01649-9 · Cited by 5
Behaviour change intervention (education and text) to prevent dental caries in secondary school pupils: BRIGHT RCT, process and economic evaluation
Marshman, Z., Ainsworth, H. R., Fairhurst, C. M., Whiteside, K., Sykes, D., Keetharuth, A. D., Yousfi, S. E., Turner, E. D., Day, P. F., Chestnutt, I. G., et al. (2024) · Health Technology Assessment · doi:10.3310/jqta2103 · Cited by 5
Challenges and Stimulating Factors for the Incorporation of Economic Considerations in Clinical Practice Guidelines: A Scoping Review
de Mortier, C. A., Yaros, J. K., van Mastrigt, G. A. P. G., Verstegen, D. M. L., Evers, S., Majoie, M., Dreesens, D. H. H., & Paulus, A. T. G. (2024) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.14264 · Cited by 7
Cost effectiveness of temporary isolation rooms in acute care settings in Singapore
Graves, N., Cai, Y., MITCHELL, B. G., Fisher, D. A., & Kiernan, M. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271739 · Cited by 5
“The time horizon for the analysis is 12 months so no discounting rate applies to costs, but health benefits measured in life years attract discounts of 3% per year [15].”
Background
Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L
Izumi, S., Hagiwara, Y., Matsuyama, Y., Shiroiwa, T., Taira, N., Kawahara, T., Konomura, K., Noto, S., Fukuda, T., & Shimozuma, K. (2023) · Health and Quality of Life Outcomes · doi:10.1186/s12955-022-02085-8 · Cited by 6
Reaching adults who smoke cigarettes in rural Appalachia: Rationale, design & analysis plan for a mixed-methods study disseminating pharmacy-delivered cessation treatment
Fahey, M. C., Krukowski, R. A., Anderson, R. T., Cohn, W. F., Porter, K., Reid, T., Wiseman, K. P., You, W., Wood, C. H., Rücker, T., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107335 · Cited by 5
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations
Courtney, P. T., Valle, L., Raldow, A. C., & Steinberg, M. L. (2023) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2023.10.014 · Cited by 5
Economic Evaluation of Videoconference Group Acceptance and Commitment Therapy and Behavioral Activation Therapy for Depression Versus Usual Care Among Adults With Chronic Low Back Pain Plus Comorbid Depressive Symptoms
Sanabria‐Mazo, J. P., D’Amico, F., Cardeñosa, E., Ferrer, M., Edo, S., Borràs, X., McCracken, L. M., Feliu‐Soler, A., Sanz, A., & Luciano, J. V. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.01.337 · Cited by 8
Targeting strategies of antenatal balanced energy and protein supplementation in Addis Ababa, Ethiopia: study protocol for a randomized effectiveness study
Wang, D., Shifraw, T., Costa, J. C., Abdelmenan, S., Tsegaye, S., Berhane, Y. Y., Gulema, H., Berhane, H. Y., Fasil, N., Workneh, F., et al. (2024) · Trials · doi:10.1186/s13063-024-08002-2 · Cited by 5
“We will use the cost data and effectiveness results to conduct an incremental cost-effectiveness analysis comparing the four intervention approaches [37, 38].”
Method
What is the Status Quo of Patient-Centred Physiotherapy Management of People with Headache within a Biopsychosocial Model? – A Narrative Review
Mingels, S., Granitzer, M., Luedtke, K., & Dankaerts, W. (2024) · Current Pain and Headache Reports · doi:10.1007/s11916-024-01306-7 · Cited by 5
Economic Evaluation Alongside a Randomized Controlled Crossover Trial of Modified Group Cognitive–Behavioral Therapy for Anxiety Compared to Treatment-as-Usual in Adults With Asperger Syndrome
Doble, B., Langdon, P. E., Shepstone, L., Murphy, G. H., Fowler, D. G., Heavens, D., Malovic, A., Russell, A., Rose, A. K., Mullineaux, L., et al. (2017) · MDM Policy & Practice · doi:10.1177/2381468317729353 · Cited by 5
Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model
Wright, J. D., Havrilesky, L. J., Cohn, D. E., Huang, Y., Rathbun, J. A., Rice, L. W., Brown, C. L., Alvarez, R. D., & Ko, E. M. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.02.011 · Cited by 5
Cost-effectiveness of preoperative magnetic resonance imaging to optimize surgery in ductal carcinoma in situ of the breast
Kandel, M., Dunant, A., Balleyguier, C., & Bonastre, J. (2020) · European Journal of Radiology · doi:10.1016/j.ejrad.2020.109058 · Cited by 5
Protocol for an economic evaluation and budget impact assessment of a randomised, stepped-wedge controlled trial for practice change support to increase routine provision of antenatal care for maternal alcohol consumption
Reeves, P., Szewczyk, Z., Kingsland, M., Doherty, E. L., Elliott, E. J., Dunlop, A. J., Searles, A., & Wiggers, J. H. (2020) · Implementation Science Communications · doi:10.1186/s43058-020-00079-5 · Cited by 5
“measures of arithmetic means, between-group differences and variability of differences [29, 30].”
Background
IVF and IUI in couples with unexplained infertility (FIIX study): study protocol of a non-inferiority randomized controlled trial
Prentice, L., Sadler, L. C., Lensen, S. F., Vercoe, M., Wilkinson, J., Edlin, R. P., Chambers, G. M., & Farquhar, C. M. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa037 · Cited by 5
“The CEA will align with good practice guidelines (Ramsey et al., 2015), with the CEA presented as incremental costs per live birth at 6 and 18 months.”
Method
Protocol for a cost–utility analysis of neurostimulation and intensive camp-based therapy for children with perinatal stroke and hemiparesis based on a multicentre clinical trial
Berrigan, P., Hodge, J. A., Kirton, A., Moretti, M. E., Ungar, W. J., & Zwicker, J. D. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041444 · Cited by 5
The economic impact of two diagnostic strategies in the management of restorations in primary teeth: a health economic analysis plan for a trial-based economic evaluation
Freitas, R. D., Moro, B. L. P., Pontes, L. R. A., Maia, H. C. D. M., Passaro, A. L., Oliveira, R. C., Garbim, J. R., Viganó, M. E. F., Tedesco, T. K., Deery, C., et al. (2021) · Trials · doi:10.1186/s13063-021-05722-7 · Cited by 5
“This manuscript is a health economic analysis plan following the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Good Research Practices Task Force Report recommendations [14] and the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) [15] checklist.”
Method
Cost-effectiveness of single-layer versus double-layer uterine closure during caesarean section on postmenstrual spotting: economic evaluation alongside a randomised controlled trial
Stegwee, S. I., Ben, Â. J., Alili, M. E., van der Voet, L. F., de Groot, C. J. M., Bosmans, J. E., & Huirne, J. A. F. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044340 · Cited by 5
Reducing problematic alcohol use in employees: economic evaluation of guided and unguided web‐based interventions alongside a three‐arm randomized controlled trial
Buntrock, C., Freund, J., Smit, F., Riper, H. M., Lehr, D., Boß, L., Berking, M., & Ebert, D. D. (2021) · Addiction · doi:10.1111/add.15718 · Cited by 5
“The execution and reporting of the health economic evaluation followed the declaration of the Consolidated Health Economic Evaluation Reporting Standards [17] and the guidelines of the International Society for Pharmacoeconomics and Results Research [18].”
Method
A Scoping Review of Item-Level Missing Data in Within-Trial Cost-Effectiveness Analysis
Ling, X.-X., Gabrio, A., Mason, A. J., & Baio, G. (2022) · Value in Health · doi:10.1016/j.jval.2022.02.009 · Cited by 5
Effectiveness and cost-effectiveness of a web-based routine assessment with integrated recommendations for action for depression and anxiety (RehaCAT+): protocol for a cluster randomised controlled trial for patients with elevated depressive symptoms in rehabilitation facilities
Knauer, J., Terhorst, Y., Philippi, P., Kallinger, S. M., Eiler, S., Kilian, R., Waldmann, T., Moshagen, M., Bader, M., & Baumeister, H. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061259 · Cited by 6
Rationale and study design: A randomized controlled trial of early palliative care in newly diagnosed cancer patients in Addis Ababa, Ethiopia
Reid, E. A., Abathun, E., Feyisa, J. D., Mamo, Y., Hall, P. S., Fallon, M., Wondemagegnhu, T., & Grant, L. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100564 · Cited by 5
Design and Rationale for the Deep South Interactive Voice Response System–Supported Active Lifestyle Study: Protocol for a Randomized Controlled Trial
Brown, N. I., Powell, M. A., Baskin, M. L., Oster, R. A., Demark‐Wahnefried, W., Hardy, C. M., Pisu, M., Thirumalai, M., Townsend, S., Neal, W. N., et al. (2021) · JMIR Research Protocols · doi:10.2196/29245 · Cited by 5
Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care
van Egmond, S., van Vliet, E. D., Wakkee, M., Hollestein, L. M., Pouwels, X., Koffijberg, H., Misirli, Y., Bakkum, R. S. L. A., Bastiaens, M. T., Kukutsch, N. A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0260978 · Cited by 5
“This decision model simulates potential effects on health outcomes and costs that patients would have made over time to estimate the effect of the intervention compared with usual care [19, 30].”
Result
The daily Self-Weighing for Obesity Management in Primary Care Study: Rationale, design and methodology
Dutton, G. R., Kinsey, A. W., Howell, C. R., Pisu, M., Dobelstein, A., Allison, D. B., Xun, P., Levitsky, D. A., & Fontaine, K. R. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106463 · Cited by 5
A randomised controlled trial investigating the clinical and cost-effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in patients seeking treatment for moderate severity depression in primary care (Alpha-Stim-D Trial)
Patel, S., Boutry, C., Patel, P., Craven, M. P., Guo, B., Zafar, A., Kai, J., Smart, D., Butler, D., Higton, F., et al. (2022) · Trials · doi:10.1186/s13063-022-06192-1 · Cited by 5
“Using this information on costs and benefits, an incremental cost-utility analysis will be conducted and reported using an accepted methodology, including a cost-effectiveness acceptability curve showing the probability that the intervention is cost-effective at a range of threshold values for the willingness to pay p…”
Method
A mindfulness-based, cognitive, social, digital relapse-prevention intervention for youth with depression in Australia: study protocol for a randomised controlled trial of Rebound
Mangelsdorf, S. N., Cagliarini, D., Lee, Y. Y., Mihalopoulos, C., Liu, V., Valentine, L., Bendall, S., Koval, P., D'Alfonso, S., Davey, C., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-088695 · Cited by 3
“Best practice within-trial economic evaluation methods will be adopted 53 ; and the comparative cost-effectiveness of the Rebound platform (vs treatment as usual) will be summarised using the incremental cost-effectiveness ratio metric (eg, cost per QALY).”
Cost-effectiveness of Transforaminal epidural steroid injections for patients with ACUTE sciatica: a randomized controlled trial
ter Meulen, B. C., Maas, E. T., Vegt, R. H. V. D., Haumann, J., Weinstein, H. C., Ostelo, R., & van Dongen, J. M. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-024-07366-5 · Cited by 4
“The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Cost Effectiveness Analysis Randomized Clinical Trial (CEA-RCT) task force therefore recommends that researchers perform CEA if positive clinical results are lacking [19].”
Background
Cost‐effectiveness of nasal high‐flow in children with acute hypoxaemic respiratory failure
Gannon, B., Franklin, D., Vo, V., Babl, F. E., & Schibler, A. (2024) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.16558 · Cited by 4
The clinical value and cost-effectiveness of treatments for patients with coronary artery disease
Weiting, H., Zhang, A. Y., Keong, Y. K., Lam, S. W., How, L. Y., Sahlén, A. O., Pourghaderi, A. R., Che, M., Terrance, C. S., & Graves, N. (2022) · Health Economics Review · doi:10.1186/s13561-022-00401-y · Cited by 4
“The perspective of the analysis was one that included health services costs and a discount rate of 3% was applied to future costs and health benefits [19].”
Method
Trial‐based economic evaluation of mindfulness‐based cognitive therapy compared to treatment as usual for bipolar disorder
Wijnen, B. F. M., Jansen, M., van Velthoven, A. S. M., Hanssen, I., Huijbers, M. J., Evers, S., & Speckens, A. E. M. (2023) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1981 · Cited by 3
“Our data analysis was performed according to the intention ‐ to ‐ treat principle (Ramsey et al., 2015).”
Method
Cost-effectiveness of a multidimensional post-discharge disease management program for heart failure patients—economic evaluation along a one-year observation period
Egelseer-Bruendl, T., Jahn, B., Arvandi, M., Puntscher, S., Santamaria, J., Brunelli, L., Weissenegger, K., Pfeifer, B. E., Neururer, S. B., Rissbacher, C., et al. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02395-5 · Cited by 5
“We incorporated all high-cost resources as well as other relevant resources that are expected to differ between treatment arms [13] and, therefore, included direct costs of the DMP and costs of HF rehospitalizations.”
BackgroundMethod
Cost-effectiveness analysis of expectant vs active management for treatment of persistent pregnancies of unknown location
Walter, J. R., Barnhart, K. T., Koelper, N., Santoro, N. F., Heping Zhang, D., Thomas, T. R., Huang, H., & Harvie, H. S. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.03.035 · Cited by 4
The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial
Welch, C., Förster, M., Ronaldson, S. J., Keding, A., Corbacho, B., & Tharmanathan, P. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02248-9 · Cited by 4
“There is also growing interest in using clinical trials to examine the cost-effectiveness of the technologies under investigation, alongside their clinical effectiveness, with the objective of assessing their ‘value for money’ to the health care system [9, 10].”
Study protocol for Sauti ya Vijana (The Voice of Youth): A hybrid-type 1 randomized trial to evaluate effectiveness and implementation of a mental health and life skills intervention to improve health outcomes for Tanzanian youth living with HIV
Mollel, G. J., Ketang’enyi, E., Komba, L., Mmbaga, B. T., Shayo, A. M., Boshe, J., Knettel, B. A., Gallis, J. A., Turner, E. L., O’Donnell, K., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305471 · Cited by 7
Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study
Sampaio, F., Langegård, U., de Alva, P. M., Flores, S., Nystrand, C., Fransson, P., Ohlsson‐Nevo, E., Kristensen, I. F., Sjövall, K., Feldman, I., et al. (2024) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-024-00577-6 · Cited by 4
Expert opinion on design and endpoints for studies on catheter ablation of atrial fibrillation
Lewalter, T., Blomström‐Lundqvist, C., Lakkireddy, D., Packer, D. L., Meyer, R., Kuniss, M., Ladwig, K., Jilek, C., Diener, H., Boriani, G., et al. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16443 · Cited by 4
Covering medical care costs for participants in the eMERGE Network: Challenges for equity and implementation
Rasmussen‐Torvik, L. J., Bonini, K. E., Harr, M. H., Abbass, M. A., Bangash, H., Bland, H. T., Boyd, B. M., Chung, W. K., Clayton, E. W., Cohen, S. J., et al. (2025) · Genetics in Medicine · doi:10.1016/j.gim.2025.101457 · Cited by 4
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms: FUTURE, a superiority RCT and economic evaluation
Abdel‐Fattah, M., Chapple, C. R., Breeman, S., Cooper, D., Bell‐Gorrod, H., Kuppanda, P. M., Guerrero, K. L., Dixon, S., Cotterill, N., Ward, K., et al. (2025) · Health Technology Assessment · doi:10.3310/ukyw4923 · Cited by 5
Determining optimal strategies for primary prevention of cardiovascular disease: a synopsis of an evidence synthesis study
Uthman, O. A., Al-Khudairy, L., Nduka, C. U., Court, R. A., Enderby, J., Anjorin, S., Mistry, H., Meléndez‐Torres, G. J., Taylor‐Phillips, S., & Clarke, A. (2025) · Health Technology Assessment · doi:10.3310/kgfa8471 · Cited by 6
“62 The use of different methodological approaches, cost perspectives and outcome measures across the studies also limits their comparability and transferability to other settings.”
What Is a Valid Mapping Algorithm in Cost-Utility Analyses? A Response From a Missing Data Perspective
Hagiwara, Y., Kawahara, T., & Shiroiwa, T. (2020) · Value in Health · doi:10.1016/j.jval.2020.03.020 · Cited by 4
An efficient approach for optimizing the cost-effective individualized treatment rule using conditional random forest
Xu, Y., Greene, T., Bress, A. P., Bellows, B. K., Zhang, Y., Zhang, Z., Kolm, P., Weintraub, W., Moran, A. S., & Shen, J. (2022) · Statistical Methods in Medical Research · doi:10.1177/09622802221115876 · Cited by 4
“First, CE analyses require a set of input parameters such as unit cost or discount rate, whose varied specifications may inform different decision rules; so, sensitivity analysis should be implemented to assess the uncertainty in parameters.(13) Other input parameters such as event rates or treatment benefits are usua…”
Background
Economic evaluation of day hospital versus intensive outpatient mentalization-based treatment alongside a randomized controlled trial with 36-month follow-up.
Blankers, M., Smits, M. L., Feenstra, D. J., Horn, E. K., Kamphuis, J. H., Bales, D. L., Lucas, Z., Remeeus, M. G. A., Dekker, J., Verheul, R., et al. (2022) · Personality Disorders Theory Research and Treatment · doi:10.1037/per0000577 · Cited by 6
“For the design and reporting of this economic evaluation, we followed the Consolidated Health Economic Evaluation Reporting Standards statement (Husereau et al., 2013) and the International Society for Pharmacoeconom-ics and Outcomes Research guideline for economic evaluation alongside RCTs (Ramsey et al., 2015).”
Cost-Effectiveness of Low-Dose Compared to Standard-Dose Alteplase for Acute Ischemic Stroke in China: A Within-Trial Economic Evaluation of the ENCHANTED Study
Si, L., Chen, X., Ouyang, M., Wang, X., Chen, G., Cao, Y.-J., Wu, G. G., Zhang, J., Zhang, J., Liu, Y., et al. (2022) · Cerebrovascular Diseases · doi:10.1159/000525869 · Cited by 4
Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial
Rautenberg, T. A., Ng, S., George, G., Moosa, M. S., McCluskey, S. M., Gilbert, R. F., Pillay, S., Aturinda, I., Ard, K. L., Muyindike, W. R., et al. (2023) · Value in Health Regional Issues · doi:10.1016/j.vhri.2022.12.006 · Cited by 4
Effect of aqueous olanexidine versus alcohol-based chlorhexidine for surgical skin antisepsis on incidence of surgical site infections in gastrointestinal surgery: multicentre randomised controlled clinical trial (OEDO trial) protocol
Takeuchi, M., Obara, H., Furube, T., Kawakubo, H., Kitago, M., Okabayashi, K., Aoyama, J., Amemiya, R., Fujisaki, H., Sano, J., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074169 · Cited by 4
Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden
Sigurðardóttir, V., Engstrom, A., Berling, P., Olofsson, T., Oldsberg, L., Sadler, S., Padilla, D. P., Melis, L., & Willems, D. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2259609 · Cited by 4
“The analyses were conducted and reported according to best-practice guidelines for reporting economic evaluations from The Professional Society for Health Economics and Outcomes Research and the Consolidated Health Economic Evaluation Reporting Standards 33,34 .”
Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT–study protocol of the PIANISSIMO study
Moens, M., Crunelle, C. L., Putman, K. D., Wuyts, E., Bultinck, F., Puyenbroeck, H. V., & Goudman, L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302842 · Cited by 4
Randomized non-inferiority trial comparing an asynchronous remotely-delivered versus clinic-delivered lifestyle intervention
Pagoto, S., Goetz, J. M., Xu, R., Wang, M. L., Palmer, L., & Lemon, S. C. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01617-0 · Cited by 5
“We estimated a within condition standard deviation (SD) of 5.5% for our primary outcome based on a previous randomized trial [28].”
Influential
Clinical outcomes and cost-effectiveness of collaborative treatment with Korean and Western medicine in patients with facial palsy: a multicenter prospective observational study
Acharya, S. R., Kim, L., & Kim, N.-K. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04910-1 · Cited by 4
“ICER was determined by dividing the incremental costs by the incremental QALYs gained [36].”
Cost-effectiveness analysis of Toripalimab regimen for extensive-stage small-cell lung cancer in China and America
Yang, J., Chen, F., Li, J., Zhou, Y., Wang, H., & Long, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1556100 · Cited by 4
“Typically, the TH for pharmacoeconomic evaluation should be suf ﬁ ciently long to obtain the full impact of the intervention measures on the costs and health outcomes of the subjects (24, 37).”
Measurement tools of resource use and quality of life in clinical trials for dementia or cognitive impairment interventions: protocol for a scoping review
Yang, F. B., Dawes, P., Leroi, I., & Gannon, B. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0418-6 · Cited by 4
“Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD. Cost-effectiveness analysis alongside clinical trials II—an ISPOR Good Research Practices Task Force report.”
Background
Cost-utility of home-based fatigue self-management versus usual care for the treatment of chronic fatigue syndrome
Meng, H., & Friedberg, F. (2017) · Fatigue Biomedicine Health & Behavior · doi:10.1080/21641846.2017.1343171 · Cited by 4
“measures for the full sample as recommended by a consensus report [44].”
Background
A SYSTEMATIC APPROACH FOR ASSESSING, IN THE ABSENCE OF FULL EVIDENCE, WHETHER MULTICOMPONENT INTERVENTIONS CAN BE MORE COST-EFFECTIVE THAN SINGLE COMPONENT INTERVENTIONS
Mewes, J. C., Steuten, L., IJzerman, M. J., & van Harten, W. H. (2017) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462317000721 · Cited by 4
Using mHealth tools to improve access, coverage and treatment of uninsured people with high cardiovascular disease risk in Argentina: a study protocol for a pragmatic cluster randomised trial
Abrahams‐Gessel, S., Beratarrechea, A. G., Irazola, V. E., Gutiérrez, L., Moyano, D. L., Fernandez, A., Ciganda, Á., Celi, L. A., Winkler, E., Rubinstein, A., et al. (2018) · BMJ Innovations · doi:10.1136/bmjinnov-2017-000255 · Cited by 4
Clinical Decision Support for Recognizing and Managing Hypertensive Blood Pressure in Youth: No Significant Impact on Medical Costs
Dehmer, S. P., Sinaiko, A. R., Trower, N. K., Asche, S. E., Ekstrom, H. L., Nordin, J. D., O’Connor, P. J., & Kharbanda, E. O. (2020) · Academic Pediatrics · doi:10.1016/j.acap.2020.01.011 · Cited by 4
A Novel Absorbable Stapler Provides Patient-Reported Outcomes and Cost-Effectiveness Noninferior to Subcuticular Skin Closure: A Prospective, Single-Blind, Randomized Clinical Trial
Malard, O., Duteille, F., Darnis, E., Espitalier, F., Perrot, P., Ferron, C., Planche, L., Hardouin, J.-B., Tessier, P., Bellanger, M. M., et al. (2020) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000007356 · Cited by 4
Children and Young People’s Health Partnership Evelina London Model of Care: economic evaluation protocol of a complex system change
Bori, M. S., Lingam, R., Satherley, R., Forman, J., Cecil, L., Fox-Rushby, J. A., & Wolfe, I. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047085 · Cited by 4
Rising drug cost impacts on cost‐effectiveness of 2 chemotherapy regimens for intermediate‐risk rhabdomyosarcoma: A report from the Children's Oncology Group
Russell, H. V., Chi, Y., Okcu, M. F., Bernhardt, M. B., Galindo, C. R., Gupta, A. A., & Hawkins, D. S. (2021) · Cancer · doi:10.1002/cncr.33917 · Cited by 4
Internet- and mobile-based intervention for depression in adults with chronic back pain: A health economic evaluation
Paganini, S., Terhorst, Y., Sander, L., Lin, J., Schlicker, S., Ebert, D. D., Berking, M., Riper, H. M., & Baumeister, H. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.004 · Cited by 5
Cost-effectiveness of thrombectomy alone versus alteplase before thrombectomy in acute ischemic stroke: results from the DIRECT-MT.
Ma, H., Zhou, Y., Gao, L., Liu, P., Zhang, L., Xing, P., Li, Z.-F., Shen, H.-J., Zhang, H.-J., Zhang, Y.-X., et al. (2023) · Journal of Neurosurgery · doi:10.3171/2022.12.jns221791 · Cited by 4
Health economic studies using transferred costs from the Middle East and North Africa region: a protocol for a systematic review of the methodology and reporting quality
Fgaier, M. (2022) · IEEE International Symposium on Intelligent Systems and Informatics (SISY) · doi:10.1109/sisy56759.2022.10036324 · Cited by 4
Cost-Utility of Attachment-Based Compassion Therapy (ABCT) and Mindfulness-Based Stress Reduction (MBSR) in the Management of Depressive, Anxious, and Adjustment Disorders in Mental Health Settings: Economic Evaluation Alongside a Randomized Controlled Trial
D’Amico, F., Navarrete, J., Montero‐Marín, J., Cardeñosa, E., Navarro‐Gil, M., Pérez‐Aranda, A., del Hoyo, Y. L., Collado‐Navarro, C., García‐Campayo, J., & Luciano, J. V. (2024) · Mindfulness · doi:10.1007/s12671-024-02319-4 · Cited by 5
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT
Drayson, M. T., Bowcock, S. J., Planche, T., Iqbal, G., Pratt, G., Yong, K., Wood, J., Raynes, K., Higgins, H. B., Dawkins, B., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23620 · Cited by 4
“5) 158 (39) 314 (38) Stable 203 (49) 204 (51) 407 (50) Worsening 47 (11) 35 (9) 82 (10) Missing 10 (2) 5 (1) 15 (2) Participant’s current bone pain None 148 (36) 160 (40) 308 (38) Mild 131 (31.”
BackgroundInfluential
Statements, Recommendations, Proposals, Guidelines, Checklists and Scales Available for Reporting Results in Biomedical Research and Quality of Conduct. A Systematic Review
Otzen, T., Manterola, C., Mora, M., Quiroz, G., Salazar, P., & García, N. (2020) · International Journal of Morphology · doi:10.4067/s0717-95022020000300774 · Cited by 7
“It does not contain a numerical rating scale (Ramsey et al., 2015).”
Background
Decision Modeling for Cost-Utility Analysis
Kuntz, K. M. (2016) · Value in Health · doi:10.1016/j.jval.2016.06.003 · Cited by 4
“This topic has been covered by another good practices task force [5].”
Background
Bayesian Statistical Economic Evaluation Methods for Health Technology Assessment
Gabrio, A., Baio, G., & Manca, A. (2019) · Oxford Research Encyclopedia of Economics and Finance · doi:10.1093/acrefore/9780190625979.013.451 · Cited by 4
“Whilst some guidelines exist for performing economic evaluations in the presence of missing outcome values (Ramsey et al., 2015), they tend not to be consistently followed in published studies, which have historically performed the analysis only on individuals with fullyobserved data (Wood et al.,…”
Background
The (cost-)effectiveness of early intervention (MBT-early) versus standard protocolized treatment (CBT) for emerging borderline personality disorder in adolescents (the EARLY study): a study protocol for a randomized controlled trial
Remeeus, M. G. A., Clarke, S. L., Feenstra, D. J., Van Eeren, H., Smits, M. L., Debruyne, S., Kouijzer, M. E. J., Luyten, P., Scholte, R. H. J., & Hutsebaut, J. (2024) · Trials · doi:10.1186/s13063-024-08095-9 · Cited by 3
“…will be covered by, for example, sensitivity analyses in which imputed uncertainty is also taken into account by repeating the economic evaluation on the imputed dataset and sampling uncertainty will be taken into account by providing a cost-effectiveness acceptability curve and frontier [67].”
BackgroundMethod
Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib Therapy
Centanni, M., Nijhuis, J., Karlsson, M. O., & Friberg, L. E. (2024) · PharmacoEconomics · doi:10.1007/s40273-024-01438-z · Cited by 3
“…Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognizes that well-conducted randomized controlled trials (RCTs) provide strong evidence for estimating treatment effects, but might bear limitations for long-term outcomes, safety data and real-world treatment patterns [3, 4].”
Economic analysis of hemodialysis and urgent-start peritoneal dialysis therapies
Brabo, A. M., Dias, D. B., da Silva, E. N., & Ponce, D. (2025) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2024-0051en · Cited by 3
“The chosen methodology more adequately replaces the construction of economic models as it is specific for primary data studies, according to guidelines on the subject 34,37 .”
Poor reporting quality and high proportion of missing data in economic evaluations alongside pragmatic trials: a cross-sectional survey
Yu, X., Song, R., Hao, J., Li, W., Wu, C., Zuo, L., Cai, Y., Zhang, X., Wu, H., & Hui, W. (2025) · BMC Medical Research Methodology · doi:10.1186/s12874-025-02519-z · Cited by 4
“Hence, pRCTs can have high external validity and offer more relevant and applicable evidence to healthcare decision-making than eRCTs [16, 17].”
Influential
Hospital admissions for undocumented immigrants: a comparative analysis of French healthcare coverage schemes
Zarca, K., Bekkar, Z., Rapp, T., Durand‐Zaleski, I., & Féral‐Pierssens, A. (2025) · European Journal of Public Health · doi:10.1093/eurpub/ckaf113 · Cited by 3
“We used the gamma distribution with a log link function for costs as an outcome variable, as recommended [14].”

Authors: Ramsey, S. D., Willke, R. J., Glick, H., Reed, S. D., Augustovski, F., Jonsson, B., Briggs, A., & Sullivan, S. D.
Affiliations: University of Washington (US)
Pfizer (United States) (US)
University of Pennsylvania (US)
Duke University (US)
Universidad de Buenos Aires (AR)
University of Glasgow (GB)
Corresponding author: Ramsey, Scott D.
ORCID: Ramsey, Scott D.
Willke, Richard J.
Reed, Shelby D.
Augustovski, Federico
Briggs, Andrew
Sullivan, Sean D.
Venue: Value in Health
Publisher: Elsevier BV
Published: 2015-03
Volume: 18
Issue: 2
Pages: 161-172
ISSN: 1098-3015 (ISSN-L)
DOI: 10.1016/j.jval.2015.02.001
OpenAlex: W2139814250
Cited by: 811
References: 184
Citations by year: 2026: 58 · 2025: 75 · 2024: 90 · 2023: 80 · 2022: 100 · 2021: 103 · 2020: 88 · 2019: 65 · 2018: 50 · 2017: 57 · 2016: 37 · 2015: 6
FWCI: 17.59
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
Locations: Value in Health (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords: cost-effectiveness analysis, clinical trials, economic evaluation, trial design, health care utilization, health utility, intention-to-treat analysis, subgroup analysis, uncertainty characterization, reporting guidelines, reimbursement decisions, healthcare resource allocation
MeSH terms: Cost-Benefit Analysis, Health Policy, Health Services Research, Humans, Randomized Controlled Trials as Topic, Advisory Committees, Research Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks